CoskunM, MukaddesNM: Possible risperidone-related gastrointestinal bleeding or epistaxis in two pediatric cases. J Child Adolesc Psychopharmacol, 18:299–300, 2008.
3.
MarcusRN, OwenR, ManosG, MankoskiR, KamenL, McQuadeRD, CarsonWH, Corey-LislePK, AmanMG: Aripiprazole in the treatment of irritability in pediatric patients (aged 6–17 years) with autistic disorder: Results from a 52-week, open-label study. J Child Adolesc Psychopharmacol, 21:229–236, 2011.
4.
OwenR, SikichL, MarcusRN, Corey-LisleP, ManosG, McQuadeRD, CarsonWH, FindlingRL: Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124:1533–1540, 2009.
5.
PrzyklenkK, FrelingerAL, LindenMD, WhittakerP, LiY, BarnardMR, AdamsJ, MorganM, Al-ShammaH and MichelsonAD: Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis. J Thromb Haemost, 8:331–340, 2010.
